Denis Migliorini Selected Research

Denis Migliorini Research Topics

22	Neoplasms (Cancer) 01/2022 - 01/2015
9	Glioblastoma (Glioblastoma Multiforme) 10/2021 - 01/2018
9	Glioma (Gliomas) 01/2020 - 11/2013
5	Brain Neoplasms (Brain Tumor) 10/2020 - 01/2015
3	Hematologic Neoplasms (Hematological Malignancy) 05/2021 - 04/2016
3	Astrocytoma (Pilocytic Astrocytoma) 11/2019 - 01/2017
2	Neoplasm Metastasis (Metastasis) 03/2021 - 10/2016
2	Hypoxia (Hypoxemia) 09/2020 - 01/2015
1	COVID-19 01/2022
1	Bites and Stings (Sting) 10/2020
1	Brain Edema (Cerebral Edema) 10/2020
1	Lymphopenia (Lymphocytopenia) 01/2020
1	Oligodendroglioma 01/2018
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2018
1	Ependymoma 01/2018
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2018
1	Meningioma (Meningiomas) 10/2017
1	Chordoma 01/2017
1	Melanoma (Melanoma, Malignant) 10/2016
1	Hemangioblastoma 01/2015

11	VaccinesIBA 01/2022 - 11/2013
5	Chimeric Antigen ReceptorsIBA 10/2021 - 01/2016
4	AntigensIBA 05/2021 - 01/2018
4	Peptides (Polypeptides)IBA 01/2020 - 01/2015
3	IMA950IBA 11/2019 - 01/2018
3	Immune Checkpoint InhibitorsIBA 12/2018 - 01/2015
3	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2015
2	AntibodiesIBA 10/2020 - 01/2017
2	Temozolomide (Temodar)FDA LinkGeneric 01/2020 - 01/2018
2	Protein Subunit VaccinesIBA 11/2019 - 04/2019
2	poly ICLCIBA 11/2019 - 04/2019
2	HLA Antigens (Human Leukocyte Antigens)IBA 11/2019 - 01/2019
2	epidermal growth factor receptor VIIIIBA 12/2018 - 01/2015
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2017 - 10/2016
1	Biomarkers (Surrogate Marker)IBA 04/2021
1	Metformin (Glucophage)FDA LinkGeneric 09/2020
1	SteroidsIBA 01/2020
1	Poly I-CIBA 11/2019
1	Carboxymethylcellulose Sodium (Polycell)FDA Link 11/2019
1	PolylysineIBA 11/2019
1	Bevacizumab (Avastin)FDA Link 04/2019
1	HLA-A*24:02 antigenIBA 01/2019
1	HLA-A Antigens (HLA-A)IBA 01/2019
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 12/2018
1	Polysaccharides (Glycans)IBA 01/2018
1	Messenger RNA (mRNA)IBA 01/2018
1	EpitopesIBA 01/2018
1	Oxidoreductases (Dehydrogenase)IBA 04/2016
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2016
1	CD40 Ligand (CD40L)IBA 11/2015
1	pazopanib FDA Link 01/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2015

14	Immunotherapy 03/2021 - 11/2013
11	Therapeutics 10/2021 - 01/2015
3	Radiotherapy 01/2020 - 10/2016
2	Drug Therapy (Chemotherapy) 09/2020 - 01/2020
2	Chemoradiotherapy 01/2020 - 11/2019
2	Cell- and Tissue-Based Therapy (Cell Therapy) 04/2016 - 01/2015
1	Oncolytic Virotherapy 10/2020
1	Adjuvant Chemotherapy 01/2020
1	Adjuvant Radiotherapy 10/2017